# MRS and 11C-methionine PET/CT in the Diagnosis of Glioma

> **NCT03009318** · NA · COMPLETED · sponsor: **Huashan Hospital** · enrollment: 100 (actual)

## Conditions studied

- Glioma

## Interventions

- **OTHER:** tumors are confirmed by surgery and pathology

## Key facts

- **NCT ID:** NCT03009318
- **Lead sponsor:** Huashan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2016-09
- **Final completion:** 2017-12
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2018-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03009318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03009318, "MRS and 11C-methionine PET/CT in the Diagnosis of Glioma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03009318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*